Fig. 2From: Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trialsOccurrence of posttransplant diabetes mellitus (PTDM) in (a) the ZEUS study (b) the HERAKLES study (Kaplan-Meier estimates) CsA, cyclosporineBack to article page